Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.

The G protein-coupled receptor P2RY2 protein of the purinergic receptor family is involved in the pathogenesis of Alzheimer's disease (AD). Naturally occurring antibodies against P2RY2 (NAbs-P2RY2) are present in human plasma, with their clinical relevance in AD unknown. To explore the alteration of NAbs-P2RY2 in AD patients and its associations with biomarkers and cognition of AD patients. The levels of naturally occurring antibodies against the four extracellular domains of P2RY2 (NAbs-P2RY2-1, NAbs-P2RY2-2, NAbs-P2RY2-3, and NAbs-P2RY2-4) were measured in the plasma of 55 AD patients, 28 non-AD dementia patients, and 70 cognitively normal participants. The correlations of autoantibody levels with cognitive scale scores, AD plasma biomarkers, and brain amyloid burden were examined. NAbs-P2RY2-1, NAbs-P2RY2-3, and NAbs-P2RY2-4 were reduced in AD patients. Plasma levels of NAbs-P2RY2-2 and NAbs-P2RY2-3 levels were positively associated with cognitive and functional performances. Among these antibodies, plasma NAbs-P2RY2-2 levels were positively associated with plasma amyloid-β 42 levels. While plasma NAbs-P2RY2-3 levels were negatively associated with brain amyloid burden in AD patients. These findings indicate an alteration of humoral immunity against P2RY2 in AD patients. Further mechanistical investigations are needed to reveal the role of NAbs-P2RY2 in the pathogenesis of AD.

Citation

Jie-Ming Jian, Dong-Yu Fan, Yuan Cheng, Ying-Ying Shen, Dong-Wan Chen, Hui-Yun Li, Yang Chen, Yuan Zhang, Gui-Hua Zeng, Cheng-Rong Tan, Yu-Hui Liu, Yan-Jiang Wang. Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2022;87(2):711-719

Mesh Tags

Substances

PMID: 35342089

search → result